Shares in UCB, the Belgian biopharma company, closed 21.6% higher at 259.10 euros on Thursday after it raised its 2026 ...

Danish drugmaker Novo (NOV: N) and US pharma major Eli Lilly (NYSE: LLY) are competing across a widening range of obesity ...

Zymeworks, the Vancouver-based biotech, has signed an exclusive global license and collaboration agreement with Roche for ...

The European Commission has approved an indication extension for Johnson & Johnson's Tecvayli (teclistamab) as monotherapy ...

US pharma major Merck & Co (NYSE: MRK) and US biotech Moderna (Nasdaq: MRNA) have reported detailed Phase III results showing ...

Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely ...

The US Treasury Department has proposed adding biotech to the sectors covered by its outbound investment rules, a move that ...

Pharmaceutical companies’ reliance on Chinese suppliers extends from early laboratory work to the production of medicines for ...

US pharma major AbbVie yesterday announced positive top-line results from the Phase III INTREPID study evaluating the safety ...

US biotech Rezera has filed for an initial public offering (IPO) to help fund late-stage development of its oral inflammation ...

Danish clinical-stage techbio Evaxion has announced new three-year immune and clinical outcome data for personalized cancer ...

Gilead Sciences revealed it has entered into a definitive agreement to acquire an oral interleukin (IL)-23R inhibitor program ...